Gara Jalqabaatti › Glioma › Maryland
Qorannoo klinikaalii Glioma Maryland keessatti
Qorannoo 11 Glioma f Maryland keessatti hirmaatuu jiru.
Magaalota Maryland keessatti
Takkalaa qorannoo (Ingiliffa)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 21 Years · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05099003Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07416188Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Johns Hopkins Sidney Kimmel Cancer Center - Baltimore, Baltimore
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07326566A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 15 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05588141Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- John Hopkins University, Baltimore
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 25 · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT04485559Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 14-Hag-2026 · NCT06344130PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
- National Institutes of Health Clinical Center, Bethesda
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06161519A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- The John Hopkins Hospital, Baltimore
- Maryland Oncology Hematology- Columbia, Rockville
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 8 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT05503797LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
- Maryland Proton Treatment Center, Baltimore
- University of Maryland Greenebaum Cancer Center, Baltimore
- UCH Kaufman Cancer Center, Bel Air
- fi 2 dabalataa
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Cam-2026 · NCT04699773Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
- National Institutes of Health, Bethesda
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Mud-2025 · NCT04541082Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas
- Rosy Njonkou Tchoquessi, Baltimore
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 22-Ful-2025 · NCT04772456Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.